Author | Silas Inman


Point-of-Care COVID-19 Test Gets FDA Authorization

March 22, 2020

FDA grants emergency use authorization to a rapid point-of-care test to detect COVID-19 infection.

Navitoclax/Ruxolitinib Combination Improves Outcomes for Patients With Myelofibrosis

December 11, 2019

Results of a recent study from ASH 2019 is suggesting a combination of navitoclax and ruxolitinib could improve outcomes for patients with myelofibrosis.

Novel Agent Shows Early Promise for Advanced Myelofibrosis

December 10, 2019

Results of the phase 2 MANIFEST study presented at ASH 2019 suggest CPI-0610 could be an effective treatment for patients with refractory or intolerant advanced myelofibrosis.

Gene Therapy GS010 Shows Intriguing Findings for LHON

October 14, 2019

The rAAV2/2-ND4 gene therapy GS010 elicited continuous bilateral improvements in BCVA from week 48 to week 96 for patients with Leber hereditary optic neuropathy.